Blog Operator Profile

How Aptive Environmental Built a 600-Branch Empire (And Why the Industry Still Doesn't Trust Them)

Aptive grew from a Utah door-knocking startup into one of the largest pest control companies in North America. How the strategy worked and what it cost.

PestBrief Editorial Team April 21, 2026 Updated May 26, 2026
aptive-environmentaldoor-to-doorgrowthcontroversyprivate-equity

Aptive Environmental shouldn’t exist at the scale it does. The company was founded in 2015 in Provo, Utah. By 2024 it was operating in dozens of states, employing thousands, generating hundreds of millions in revenue, and ranked among the largest pest control companies in North America by branch count. That kind of growth almost never happens in service businesses — and when it does, it usually leaves a mess behind.

Aptive’s growth left a mess.

What follows isn’t a hit piece. Aptive is a real company, with real customers, real employees, and real operational capability. But understanding how Aptive scaled — and the cost of how they scaled — is necessary for anyone in the industry trying to make sense of where pest control is heading. The Aptive model is now being copied, in modified form, by several newer entrants. Whether that’s good for the industry is an open question.

The door-to-door engine

Aptive was built on summer sales. The founding team came out of Utah’s well-known door-to-door industry — the same talent pool that produced Vivint, Pinnacle, and a half dozen pest control companies before Aptive. The model is simple in theory: hire college students, pay them on commission, send them door-to-door in residential neighborhoods during the summer, sign up customers on multi-treatment annual contracts, and let the recurring revenue do the rest.

In practice, the model is unforgiving. Sales reps work brutal hours. Customer churn is high. The contracts customers sign are aggressive — often locking in annual commitments with substantial cancellation fees. Complaints to state attorneys general and consumer protection agencies followed Aptive’s expansion almost from day one.

But the math worked. Each summer sales cycle generated thousands of new contracts. Each contract had a long enough commitment to make the lifetime value clear. The company poured the resulting cash flow back into more sales, more geography, more service infrastructure.

By 2020, Aptive was already among the fastest-growing pest control companies in the country. By 2024, branch count had passed 600.

The Goldman investment

In 2023, Goldman Sachs Asset Management took a majority stake in Aptive. The deal validated the financial model and gave Aptive the balance sheet to accelerate further. It also marked a shift — from scrappy door-to-door operation to institutional-backed platform.

What’s interesting about the Goldman deal isn’t the price (largely undisclosed) or the structure (typical PE majority recap). It’s the timing. Aptive had been on the receiving end of significant regulatory and reputational scrutiny for years. Multiple state AGs had opened investigations. The Better Business Bureau had downgraded the company’s rating. And yet Goldman wrote the check.

The lesson, depending on your view: either institutional capital sees through the noise to a fundamentally sound business model, or institutional capital is willing to overlook reputational concerns when the financials are compelling. Probably both.

What Aptive looks like operationally today

Today’s Aptive isn’t just the door-to-door company it started as. The company has spent the post-Goldman years professionalizing operations — hiring industry veterans, building out commercial divisions, investing in technology, and trying to soften the reputational edges of the early years.

The reality on the ground is more mixed. Aptive still recruits heavily through the summer sales model. Customer complaints still surface regularly. The company has paid settlements in multiple states over sales practices, contract terms, and pesticide handling. But operationally, Aptive is a real company. They actually treat homes. They actually have technicians. They actually retain a meaningful percentage of their customers year over year.

For competitors, the question is what to make of all this. Aptive’s growth has scrambled markets across the country. In suburban geographies where established local operators had near-monopoly density, Aptive has knocked on every door and signed up enough customers to matter. Operators we talk to describe Aptive’s arrival in a market with a mixture of frustration and grudging respect.

Why Aptive matters for industry M&A

The Aptive model has implications for everyone else in the industry. Three worth flagging:

First, the customer acquisition cost math. Aptive proved you can build pest control market share at scale through direct sales rather than through SEO, referrals, or acquisition. Whether the unit economics actually work over a customer’s lifetime is debated — Aptive’s churn rates aren’t public — but the topline growth is undeniable. Other operators are now trying to replicate elements of the model.

Second, the multi-state platform question. Aptive showed that you can run a 600-branch pest control company without buying anyone. They built almost entirely organically. That’s a counterweight to the dominant industry narrative that scale only comes through M&A. For PE platforms evaluating organic vs acquisition growth, Aptive is an important data point.

Third, the reputational ceiling. Aptive has shown both what unconstrained growth can achieve and what it can cost. For competitors trying to build similar businesses without the regulatory baggage, the path is narrower than Aptive’s success makes it look.

What’s next for Aptive

The Goldman ownership creates a clock. PE majority deals generally target a 5–7 year hold. That means the next chapter for Aptive — sale, IPO, recapitalization, or some combination — is coming inside the next few years.

Who buys it is an interesting question. Rentokil and Rollins are obvious candidates on paper, but the cultural integration challenges would be significant. A larger PE platform doing a secondary buyout is more likely. An IPO is possible but unlikely given the regulatory exposure.

Whatever happens, Aptive’s exit will be one of the defining transactions in the next phase of pest control consolidation. Watch this space.

Frequently asked questions

Is Aptive Environmental publicly traded?

No. Aptive is privately held, with Goldman Sachs Asset Management holding a majority stake since 2023.

How many branches does Aptive operate?

Over 600 branches across North America as of late 2024, making it one of the largest pest control operators by branch count.

How does Aptive acquire customers?

Primarily through door-to-door sales, often executed by seasonal sales teams during summer months. This model has been a source of both rapid growth and reputational concerns.

Has Aptive Environmental been sued?

Aptive has faced regulatory actions, consumer complaints, and lawsuits in multiple states over sales practices, contract terms, and other issues. The company has paid settlements in several jurisdictions.

Who owns Aptive Environmental?

Goldman Sachs Asset Management holds a majority stake following a 2023 investment. The founding team retains a meaningful minority position and remains involved operationally.

For more on PE-backed pest control growth strategies, see Anticimex’s Sun Belt strategy or compare door-to-door vs traditional growth in our Anticimex vs Aptive comparison.

The weekly brief

Get Monday's M&A intelligence, free.

Every Monday: deal closes, operator signals, and M&A trends across 6,000+ Texas PCOs. Joining 400+ acquirers and suppliers.